[HTML][HTML] WEE1 inhibitor: clinical development

A Kong, H Mehanna - Current oncology reports, 2021 - Springer
Purpose of Review WEE1 inhibitor has been shown to potential chemotherapy or
radiotherapy sensitivity in preclinical models, particularly in p53-mutated or deficient cancer …

[HTML][HTML] Statistical methods and data visualisation of patient-reported outcomes in early phase dose-finding oncology trials: a methodological review

E Alger, A Minchom, OL Aiyegbusi, M Schipper… - …, 2023 - thelancet.com
Background Traditionally, within dose-finding clinical trials, treatment toxicity and tolerability
are assessed by clinicians. Research has shown that clinician reporting may have …

Mechanism of tumour microenvironment in the progression and development of oral cancer

M Mughees, A Sengupta, S Khowal, S Wajid - Molecular biology reports, 2021 - Springer
Oral cancer has been a major problem all across the globe, majorly in the developing
countries. With a growing emphasis in the field of cancer research, the contribution of the …

[HTML][HTML] Key Proteins of Replication Stress Response and Cell Cycle Control as Cancer Therapy Targets

AI Khamidullina, YE Abramenko, AV Bruter… - International Journal of …, 2024 - mdpi.com
Replication stress (RS) is a characteristic state of cancer cells as they tend to exchange
precision of replication for fast proliferation and increased genomic instability. To overcome …

[HTML][HTML] Targeting DNA damage response as a potential therapeutic strategy for head and neck squamous cell carcinoma

H Lei, A He, Y Jiang, M Ruan, N Han - Frontiers in Oncology, 2022 - frontiersin.org
Cells experience both endogenous and exogenous DNA damage daily. To maintain
genome integrity and suppress tumorigenesis, individuals have evolutionarily acquired a …

[HTML][HTML] Dual inhibition of PARP and the intra-S/G2 cell cycle checkpoints results in highly effective radiosensitization of HPV-positive HNSCC cells

K Hintelmann, T Berenz, M Kriegs… - Frontiers in …, 2021 - frontiersin.org
In head and neck squamous cell carcinoma (HNSCC), tumors positive for human
papillomavirus (HPV) represent a distinct biological entity with favorable prognosis. An …

[HTML][HTML] Targeted treatment of head and neck (pre) cancer: preclinical target identification and development of novel therapeutic applications

AM van Harten, RH Brakenhoff - Cancers, 2021 - mdpi.com
Head and neck squamous cell carcinomas (HNSCC) develop in the mucosal lining of the
upper-aerodigestive tract. In carcinogen-induced HNSCC, tumors emerge from …

Boron Neutron Capture Therapy Eliminates Radioresistant Liver Cancer Cells by Targeting DNA Damage and Repair Responses

CY Huang, ZY Lai, TJ Hsu, FI Chou… - Journal of …, 2022 - Taylor & Francis
Introduction For advanced hepatocellular carcinoma (HCC), resistance to conservative
treatments remains a challenge. In previous studies, the therapeutic effectiveness and DNA …

[HTML][HTML] Assessment of the Mutation Profile of Tonsillar Squamous Cell Carcinomas Using Targeted Next-Generation Sequencing

HY Park, JS Lee, JH Wee, JW Kang, ES Kim, T Koo… - Biomedicines, 2023 - mdpi.com
Data regarding driver mutation profiles in tonsillar squamous cell carcinomas (TSCCs)
remain scarce, limiting the understanding of its pathogenesis and unexpected behavior in …

WEE1 kinase inhibitor MK‐1775 sensitizes oral tongue squamous cell carcinoma cells to radiation irrespective of TP53 status

AH Al‐Jamaei, JGAM de Visscher… - Oral …, 2023 - Wiley Online Library
Objective Oral tongue squamous cell carcinoma (OTSCC) frequently harbors non‐functional
p53 and depends on G2/M checkpoint mediated by WEE1. WEE1 suppression has been …